Musculoskeletal Disorders
From the Journals
ATV use by children still leads to significant trauma center admittance
Running off the road or not, all-terrain vehicles aren’t for kids.
Conference Coverage
Sustained remission on biologics bodes well for children with JIA
MADRID – Seventy percent of those in remission for at least 1.5 years remained in remission after stopping their biologic agent.
Conference Coverage
VIDEO: Tocilizumab tested in children with sJIA under 2 years old
MADRID – A few serious cases of hypersensitivity were the only concerns.
Conference Coverage
VIDEO: Childhood second-hand smoke boosts RA incidence
Childhood second-hand smoke exposure correlated to RA as in active smokers.
Conference Coverage
Comorbidities emerge in adulthood for many patients with JIA
More than half of these patients have at least one comorbidity.
Conference Coverage
Antacid use in infants linked to increased fracture risk
Proton pump inhibitors apparently are not as benign as once thought.
Pearce-Ings
Pes planus: To treat or not to treat
Classifying the type of flat feet a child has is the first of several difficulties in treating this common problem.
From the Journals
Methotrexate prolonged efficacy of steroid injections in oligoarticular JIA
The combination of intra-articular corticosteroids and methotrexate could take center stage in treat-to-target strategies for children with...
From the Journals
Opinions vary considerably on withdrawing drugs in clinically inactive JIA
There’s no one way to stop or taper medications for young patients with clinically inactive JIA.
From the Journals
Genetic studies link JIA subtypes to adult diseases, show uniqueness of systemic disease
Two new studies of the genetic relationships between the seven designated categories of juvenile idiopathic arthritis provide compelling support...
News from the FDA/CDC
First drug for spinal muscular atrophy approved
The antisense oligonucleotide drug nusinersen is the first therapy approved by the U.S. Food and Drug Administration to treat children and adults...